Preclinical and clinical studies of ARDS have shown that corticosteroid treatment rescues the cellular concentrations and functions of glucocorticoid receptors, which can lead to biological improvement and disease resolution [38]. Here, NR3C1 is linked to acute respiratory distress syndrome.